Navigation Links
Lumenis Ltd. Announces Appointment of Corporate Vice President, Business Development in support of the company's long-term growth strategy

Gideon Sturlesi has been named new Corporate Vice President, Business Development to spearhead global business activities. Lumenis reaffirms its commitment to growing its business and moving forward strongly on many

strategic fronts

YOKNEAM, Israel, Oct. 18 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications, announced the appointment of Gideon Sturlesi, a highly experienced executive in the medical devices industry, as Corporate Vice President, Business Development, effective November 18th 2007.

In addition to leading the corporate business development initiatives, Gideon will be responsible for managing the Lumenis veterinarian and dental activities, as well as the company's intellectual property strategy and portfolio.

Gideon Sturlesi was the founder and general partner of BioMedical Israel Ltd., a life-science private fund group, heading successful M&A processes, turn-arounds and "hands-on" management in it's portfolio companies. In addition, Gideon is a Venture Partner in the Ofer Hi-Tech Group, a leading investment company in life science technology-based businesses from pre-seed through early stages to public offerings. He was also the co-founder of Galil Medical Ltd., a developer of minimal invasive devices for use in urology, general surgery and other applications. Gideon Sturlesi holds a BSc and MSc (cum-laude) from the Technion Institute of Technology, Israel, and holds over 7 patents and publications in medical device technology.

Dov Ofer, CEO of Lumenis said: "We are proud to have Gideon Sturlesi as part of our executive management team. Gideon's background and proven capabilities will have a significant contribution in implementing our aggressive growth strategies. Gideon's appointment also supports the emphasis the company places on our intellectual property portfolio, one of Lumenis' major assets. With Gideon's appointment we have completed the line-up of our executive management team which is fully focused on executing our growth and profitability plans. I look forward to working hand in hand with our outstanding management team and Board of Directors to achieve Lumenis' fullest potential for the benefit of our customers, shareholders, employees and business partners."

About Lumenis Ltd.

Lumenis Ltd. is a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis Ltd. invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis Ltd. and its products, log onto:

Lumenis(R) is a registered trademark of Lumenis Ltd.

SOURCE Lumenis Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that ... 2015 at 11:00 a.m. Israel time, at the ... Yigal Allon Street, 36 th Floor, Tel Aviv, Israel ... Paneth and Izhak Tamir to the Board of Directors; ... external directors; , approval of an amendment to certain terms of ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):